Sepsis as a model of SIRS

Frontiers in Bioscience

Volumn 14, Issue 12, 2009, Pages 4703-4711

  Bhatia, Madhav ^a   He, Min ^a   Zhang, Huili ^a   Moochhala, Shabbir ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DSO NATIONAL LABORATORIES   (Singapore)

Author keywords

Chemokines; Hydrogen sulfide; Rat; Review; Sepsis; Mouse; Substance P

Indexed keywords

ANIMALIA; RATTUS;

AUTACOID;

ANIMAL; DISEASE MODEL; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 63849135992     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3561     Document Type: Article

References (61)

1. Bone R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, W. J. Sibbald: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101, 1644-55, (1992)
2. Astiz M. E. E. C. Rackow: Septic shock. Lancet 351, 1501-5, (1998)
3. Martin G. S., D. M. Mannino, S. Eaton, M. Moss: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348, 1546-54, (2003) (Pubitemid 36437931)
4. Riedemann N. C., R. F. Guo, P. A. Ward: The enigma of sepsis. J Clin Invest 112, 460-7, (2003) (Pubitemid 38056327)
5. Wichterman K. A., A. E. Baue, I. H. Chaudry: Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 29, 189-201, (1980) (Pubitemid 10039498)
6. Fink M. P. S. O. Heard: Laboratory models of sepsis and septic shock. J Surg Res 49, 186-96, (1990)
7. Buras J. A., B. Holzmann, M. Sitkovsky: Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4, 854-65, (2005) (Pubitemid 41553966)
8. Rietschel E. T., U. Schade, M. Jensen, H. W. Wollenweber, O. Luderitz, S. G. Greisman: Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl 31, 8-21, (1982) (Pubitemid 12108952)
9. Greenfield L. J., R. H. Jackson, R. C. Elkins, J. J. Coalson, L. B. Hinshaw: Cardiopulmonary effects of volume loading of primates in endotoxin shock. Surgery 76, 560-72, (1974)
10. Pappova E., B. Urbaschek, L. Heitmann, M. Oroz, E. Streit, A. Lemeunier, P. Lundsgaard-Hansen: Energy-rich phosphates and glucose metabolism in early endotoxin shock. J Surg Res 11, 506-12, (1971)
11. Swan K. G. E. D. Jacobson: Hemodynamics of endotoxin shock in the conscious animal. Surg Gynecol Obstet 125, 1041-6, (1967)
12. Swan K. G. D. G. Reynolds: Blood flow to the liver and spleen during endotoxin shock in the baboon. Surgery 72, 388-94, (1972)
13. Willerson J. T., R. L. Trelstad, T. Pincus, S. B. Levy, S. M. Wolff: Subcellular Localization of Salmonella enteritidis Endotoxin in Liver and Spleen of Mice and Rats. Infect Immun 1, 440-445, (1970)
14. Remick D. G., D. E. Newcomb, G. L. Bolgos, D. R. Call: Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13, 110-6, (2000)
15. Cross A. S., S. M. Opal, J. C. Sadoff, P. Gemski: Choice of bacteria in animal models of sepsis. Infect Immun 61, 2741-7, (1993) (Pubitemid 23182264)
16. Thal A. P., R. G. Robinson, T. Nagamine, R. Pruett, A. V. Wegst: The critical relationship of intravascular blood volume and vascular capacitance in sepsis. Surg Gynecol Obstet 143, 17-22, (1976)
17. Browne M. K. G. B. Leslie: Animal models of peritonitis. Surg Gynecol Obstet 143, 738-40, (1976)
18. Perkash I., P. Satpati, K. C. Agarwal, R. N. Chakravarti, P. N. Chhuttani: Prolonged peritoneal lavage in fecal peritonitis. Surgery 68, 842-5, (1970)
19. Sleeman H. K., J. W. Diggs, D. K. Hayes, H. F. Hamit: Value of antibiotics, corticosteroids, and peritoneal lavage in the treatment of experimental peritonitis. Surgery 66, 1060-6, (1969)
20. Decker G. A., A. M. Daniel, S. Blevings, L. D. Maclean: Effect of peritonitis on mitochondrial respiration. J Surg Res 11, 528-32, (1971)
21. Hau T. R. L. Simmons: Animal models of peritonitis. Surg Gynecol Obstet 144, 755-6, (1977)
22. Weinstein W. M., A. B. Onderdonk, J. G. Bartlett, S. L. Gorbach: Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun 10, 1250-5, (1974)
23. Bartlett J. G., A. B. Onderdonk, T. Louie, D. L. Kasper, S. L. Gorbach: A review. Lessons from an animal model of intra-abdominal sepsis. Arch Surg 113, 853-7, (1978) (Pubitemid 8386200)
24. Onderdonk A. B., J. G. Bartlett, T. Louie, N. Sullivan-Seigler, S. L. Gorbach: Microbial synergy in experimental intra-abdominal abscess. Infect Immun 13, 22-6, (1976)
25. Hermreck A. S., R. A. Berg, J. R. Ruhlen, R. I. MacArthur: Renal response in sepsis. Arch Surg 107, 169-75, (1973)
26. Hermreck A. S. A. P. Thal: Mechanisms for the high circulatory requirements in sepsis and septic shock. Ann Surg 170, 677-95, (1969)
27. Walker H. L., A. D. Mason, Jr., G. L. Raulston: Surface Infection with Pseudomonas Aeruginosa. Ann Surg 160, 297-305, (1964)
28. LaNoue K. F., A. D. Mason, Jr., J. P. Daniels: The impairment of glucogenesis by gram negative infection. Metabolism 17, 606-11, (1968)
29. Zantl N., A. Uebe, B. Neumann, H. Wagner, J. R. Siewert, B. Holzmann, C. D. Heidecke, K. Pfeffer: Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 66, 2300-9, (1998) (Pubitemid 28194134)
30. Cohen J.: The immunopathogenesis of sepsis. Nature 420, 885-91, (2002) (Pubitemid 36019643)
31. Borden E. C. P. Chin: Interleukin-6: a cytokine with potential diagnostic and therapeutic roles. J Lab Clin Med 123, 824-9, (1994) (Pubitemid 2103598)
32. Blackwell T. S. J. W. Christman: Sepsis and cytokines: current status. Br J Anaesth 77, 110-7, (1996)
33. Waage A., P. Brandtzaeg, A. Halstensen, P. Kierulf, T. Espevik: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169, 333-8, (1989) (Pubitemid 19035565)
34. Waage A., A. Halstensen, T. Espevik: Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1, 355-7, (1987) (Pubitemid 17010024)
35. Remick D. G., R. G. Kunkel, J. W. Larrick, S. L. Kunkel: Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 56, 583-90, (1987) (Pubitemid 17095929)
36. Remick D. G.: Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr Pharm Des 9, 75-82, (2003) (Pubitemid 36131707)
37. Libert C., A. Vink, P. Coulie, P. Brouckaert, B. Everaerdt, J. Van Snick, W. Fiers: Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. Eur J Immunol 22, 2625-30, (1992)
38. van der Poll T., M. Levi, C. E. Hack, H. ten Cate, S. J. van Deventer, A. J. Eerenberg, E. R. de Groot, J. Jansen, H. Gallati, H. R. Buller, et al.: Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179, 1253-9, (1994) (Pubitemid 24091784)
39. Lin X., H. Yang, T. Sakuragi, M. Hu, L. L. Mantell, S. Hayashi, Y. Al-Abed, K. J. Tracey, L. Ulloa, E. J. Miller: Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis. Am J Physiol Lung Cell Mol Physiol 289, L583-90, (2005) (Pubitemid 41361668)
40. Kaneider N. C., A. Agarwal, A. J. Leger, A. Kuliopulos: Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat Med 11, 661-5, (2005) (Pubitemid 40868307)
41. Ness T. L., C. M. Hogaboam, R. M. Strieter, S. L. Kunkel: Immunomodulatory role of CXCR2 during experimental septic peritonitis. J Immunol 171, 3775-84, (2003) (Pubitemid 37254583)
42. Reutershan J., M. A. Morris, T. L. Burcin, D. F. Smith, D. Chang, M. S. Saprito, K. Ley: Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J Clin Invest 116, 695-702, (2006) (Pubitemid 43326878)
43. Leitner J. M., F. B. Mayr, C. Firbas, A. O. Spiel, B. Steinlechner, R. Novellini, B. Jilma: Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia. Int J Immunopathol Pharmacol 20, 25-36, (2007) (Pubitemid 46506873)
44. Ness T. L., K. J. Carpenter, J. L. Ewing, C. J. Gerard, C. M. Hogaboam, S. L. Kunkel: CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis. J Immunol 173, 6938-48, (2004) (Pubitemid 39541082)
45. Speyer C. L., H. Gao, N. J. Rancilio, T. A. Neff, G. B. Huffnagle, J. V. Sarma, P. A. Ward: Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am J Pathol 165, 2187-96, (2004) (Pubitemid 39578395)
46. He M., R. Horuk, S. M. Moochhala, M. Bhatia: Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsis. Am J Physiol Gastrointest Liver Physiol 292, G1173-80, (2007) (Pubitemid 46557776)
47. Carter M. S. J. E. Krause: Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma. J Neurosci 10, 2203-14, (1990)
48. Beer S., H. Weighardt, K. Emmanuilidis, M. D. Harzenetter, E. Matevossian, C. D. Heidecke, H. Bartels, J. R. Siewert, B. Holzmann: Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit Care Med 30, 1794-8, (2002) (Pubitemid 34879593)
49. Puneet P., A. Hegde, S. W. Ng, H. Y. Lau, J. Lu, S. M. Moochhala, M. Bhatia: Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis. J Immunol 176, 3813-20, (2006) (Pubitemid 43364030)
50. Hegde A., H. Zhang, S. M. Moochhala, M. Bhatia: Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis. J Leukoc Biol 82, 678-85, (2007) (Pubitemid 47367160)
51. Sun J., R. D. Ramnath, M. Bhatia: Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils. Am J Physiol Cell Physiol 293, C696-704, (2007) (Pubitemid 47235187)
52. Cauwels, A.: Nitric oxide in shock. Kidney Int 72, 557-65, (2007) (Pubitemid 47312788)
53. Ryter S., A. Choi: Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models. Novartis Found Symp 280, 165-75, (2007)
54. Hui Y., J. Du, C. Tang, G. Bin, H. Jiang: Changes in arterial hydrogen sulfide (H (2) S) content during septic shock and endotoxin shock in rats. J Infect 47, 155-60, (2003) (Pubitemid 36896399)
55. Li L., M. Bhatia, Y. Z. Zhu, Y. C. Zhu, R. D. Ramnath, Z. J. Wang, F. B. Anuar, M. Whiteman, M. Salto-Tellez, P. K. Moore: Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. Faseb J 19, 1196-8, (2005) (Pubitemid 40946463)
56. Collin M., F. B. Anuar, O. Murch, M. Bhatia, P. K. Moore, C. Thiemermann: Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol 146, 498-505, (2005) (Pubitemid 41487065)
57. Zhang H., L. Zhi, P. K. Moore, M. Bhatia: Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 290, L1193-201, (2006) (Pubitemid 43830864)
58. Zhang H., L. Zhi, S. Moochhala, P. K. Moore, M. Bhatia: Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB. Am J Physiol Lung Cell Mol Physiol 292, L960-71, (2007) (Pubitemid 46608243)
59. Zhang H., L. Zhi, S. M. Moochhala, P. K. Moore, M. Bhatia: Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis. J Leukoc Biol 82, 894-905, (2007) (Pubitemid 47511050)
60. Zhang H., A. Hegde, S. W. Ng, S. Adhikari, S. M. Moochhala, M. Bhatia: Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung injury. J Immunol 179, 4153-60, (2007)
61. Healy D. P.: New and emerging therapies for sepsis. Ann Pharmacother 36, 648-54, (2002) (Pubitemid 34270282)